These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 9166076

  • 1. Modification of the response of a quiescent cell population within a murine solid tumour to boron neutron capture irradiation: studies with nicotinamide and hyperthermia.
    Masunaga S, Ono K, Suzuki M, Takagaki M, Sakurai Y, Kobayashi T, Akuta K, Akaboshi M, Kinashi Y, Abe M.
    Br J Radiol; 1997 Apr; 70(832):391-8. PubMed ID: 9166076
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of apoptosis and micronucleation induced by reactor neutron beams with two different cadmium ratios in total and quiescent cell populations within solid tumors.
    Masunaga S, Ono K, Sakurai Y, Takagaki M, Kobayashi T, Kinashi Y, Suzuki M.
    Int J Radiat Oncol Biol Phys; 2001 Nov 01; 51(3):828-39. PubMed ID: 11697329
    [Abstract] [Full Text] [Related]

  • 3. Applicability of the 2-nitroimidazole-sodium borocaptate-10B conjugate, TX-2060, as a 10B-carrier in boron neutron capture therapy.
    Masunaga S, Nagasawa H, Hiraoka M, Sakurai Y, Uto Y, Hori H, Nagata K, Suzuki M, Maruhashi A, Kinashi Y, Ono K.
    Anticancer Res; 2004 Nov 01; 24(5A):2975-83. PubMed ID: 15517904
    [Abstract] [Full Text] [Related]

  • 4. The usefulness of mild temperature hyperthermia combined with a newly developed hypoxia-oriented 10B conjugate compound, TX-2100, for boron neutron capture therapy.
    Masunaga S, Nagasawa H, Sakurai Y, Uto Y, Hori H, Nagata K, Suzuki M, Maruhashi A, Kinashi Y, Ono K.
    Int J Hyperthermia; 2006 Jun 01; 22(4):287-99. PubMed ID: 16754350
    [Abstract] [Full Text] [Related]

  • 5. Response of quiescent and total tumor cells in solid tumors to neutrons with various cadmium ratios.
    Masunaga S, Ono K, Sakurai Y, Takagaki M, Kobayashi T, Suzuki M, Kinashi Y, Akaboshi M.
    Int J Radiat Oncol Biol Phys; 1998 Jul 15; 41(5):1163-70. PubMed ID: 9719128
    [Abstract] [Full Text] [Related]

  • 6. Combination of the vascular targeting agent ZD6126 with boron neutron capture therapy.
    Masunaga S, Sakurai Y, Suzuki M, Nagata K, Maruhashi A, Kinash Y, Ono K.
    Int J Radiat Oncol Biol Phys; 2004 Nov 01; 60(3):920-7. PubMed ID: 15465210
    [Abstract] [Full Text] [Related]

  • 7. Responses of total and quiescent cell populations in solid tumors to boron and gadolinium neutron capture reaction using neutrons with two different energy spectra.
    Masunaga S, Ono K, Sakurai Y, Suzuki M, Takagaki M, Kobayashi T, Kinashi Y, Akaboshi M.
    Jpn J Cancer Res; 1998 Jan 01; 89(1):81-8. PubMed ID: 9510480
    [Abstract] [Full Text] [Related]

  • 8. Alteration of sensitivity of intratumor quiescent and total cells to gamma-rays following thermal neutron irradiation with or without 10B-compound.
    Masunaga S, Ono K, Suzuki M, Sakurai Y, Kobayashi T, Takagaki M, Kinashi Y, Akaboshi M.
    Int J Radiat Oncol Biol Phys; 2000 Feb 01; 46(3):653-9. PubMed ID: 10701745
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of the potential of p-boronophenylalaninol as a boron carrier in boron neutron capture therapy, referring to the effect on intratumor quiescent cells.
    Masunaga SI, Ono K, Kirihata M, Takagaki M, Sakurai Y, Kinashi Y, Kobayashi T, Nagasawa H, Uto Y, Hori H.
    Jpn J Cancer Res; 2001 Sep 01; 92(9):996-1007. PubMed ID: 11572769
    [Abstract] [Full Text] [Related]

  • 10. Reoxygenation in quiescent and total intratumor cells following thermal neutron irradiation with or without (10)B-compound-compared with that after gamma-ray irradiation.
    Masunaga S, Ono K, Suzuki M, Sakurai Y, Kobayashi T, Takagaki M, Kinashi Y, Akaboshi M.
    Int J Radiat Oncol Biol Phys; 1999 May 01; 44(2):391-8. PubMed ID: 10760435
    [Abstract] [Full Text] [Related]

  • 11. Repair of potentially lethal damage by total and quiescent cells in solid tumors following a neutron capture reaction.
    Masunaga S, Ono K, Suzuki M, Sakurai Y, Takagaki M, Kobayashi T, Kinashi Y, Akaboshi M.
    J Cancer Res Clin Oncol; 1999 Nov 01; 125(11):609-14. PubMed ID: 10541967
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of hypoxia-specific cytotoxic bioreductive agent-sodium borocaptate-10B conjugates as 10B-carriers in boron neutron capture therapy.
    Masunaga S, Nagasawa H, Gotoh K, Sakurai Y, Uto Y, Hori H, Nagata K, Suzuki M, Maruhashi A, Kinashi Y, Ono K.
    Radiat Med; 2006 Feb 01; 24(2):98-107. PubMed ID: 16715670
    [Abstract] [Full Text] [Related]

  • 13. Impact of the p53 status of the tumor cells on the effect of reactor neutron beam irradiation, with emphasis on the response of intratumor quiescent cells.
    Masunaga S, Ono K, Takahashi A, Sakurai Y, Ohnishi K, Kobayashi T, Kinashi Y, Takagaki M, Ohnishi T.
    Jpn J Cancer Res; 2002 Dec 01; 93(12):1366-77. PubMed ID: 12495477
    [Abstract] [Full Text] [Related]

  • 14. Potential of alpha-amino alcohol p-boronophenylalaninol as a boron carrier in boron neutron capture therapy, regarding its enantiomers.
    Masunaga S, Ono K, Kirihata M, Takagaki M, Sakurai Y, Kinashi Y, Kobayashi T, Suzuki M, Nagata K, Nagasawa H, Uto Y, Hori H.
    J Cancer Res Clin Oncol; 2003 Jan 01; 129(1):21-8. PubMed ID: 12618897
    [Abstract] [Full Text] [Related]

  • 15. Applicability of combination with tirapazamine in boron neutron capture therapy.
    Masunaga S, Ono K, Sakurai Y, Hori H, Kobayashi T, Takagaki M, Suzuki M, Kinashi Y, Akaboshi M.
    Jpn J Cancer Res; 1998 Jul 01; 89(7):768-74. PubMed ID: 9738984
    [Abstract] [Full Text] [Related]

  • 16. Effects of employing a ¹⁰B-carrier and manipulating intratumour hypoxia on local tumour response and lung metastatic potential in boron neutron capture therapy.
    Masunaga S, Sakurai Y, Tanaka H, Suzuki M, Liu Y, Kondo N, Maruhashi A, Kinashi Y, Ono K.
    Br J Radiol; 2012 Mar 01; 85(1011):249-58. PubMed ID: 22391496
    [Abstract] [Full Text] [Related]

  • 17. Delivery of (10)boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy.
    Obayashi S, Kato I, Ono K, Masunaga S, Suzuki M, Nagata K, Sakurai Y, Yura Y.
    Oral Oncol; 2004 May 01; 40(5):474-82. PubMed ID: 15006618
    [Abstract] [Full Text] [Related]

  • 18. Modification of tirapazamine-induced cytotoxicity in combination with mild hyperthermia and/or nicotinamide: reference to effect on quiescent tumour cells.
    Masunaga S, Ono K, Hori H, Kinashi Y, Suzuki M, Takagaki M, Kasai S, Nagasawa H, Uto Y.
    Int J Hyperthermia; 1999 May 01; 15(1):7-16. PubMed ID: 10193753
    [Abstract] [Full Text] [Related]

  • 19. Usefulness of combination with both continuous administration of hypoxic cytotoxin and mild temperature hyperthermia in boron neutron capture therapy in terms of local tumor response and lung metastatic potential.
    Masunaga SI, Sakurai Y, Tanaka H, Takata T, Suzuki M, Sanada Y, Tano K, Maruhashi A, Ono K.
    Int J Radiat Biol; 2019 Dec 01; 95(12):1708-1717. PubMed ID: 31545117
    [Abstract] [Full Text] [Related]

  • 20. Augmentation in chemosensitivity of intratumor quiescent cells by combined treatment with nicotinamide and mild hyperthermia.
    Masunaga S, Ono K, Akaboshi M, Kawai K, Suzuki M, Kinashi Y, Takagaki M.
    Jpn J Cancer Res; 1997 Aug 01; 88(8):770-7. PubMed ID: 9330609
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.